Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.06% Nasdaq Up0.11%

Pacific Biosciences of California, Inc. (PACB)

-NasdaqGS

2.46 Up 0.04(1.65%) 10:24AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 5,578   5,878   2,776   7,291  
Cost of Revenue4,648  5,251  2,586  7,016  
Gross Profit 930   627   190   275  
Operating Expenses
Research Development11,983  11,652  12,626  11,272  
Selling General and Administrative9,554  10,669  10,143  11,558  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (20,607) (21,694) (22,579) (22,555)
Income from Continuing Operations
Total Other Income/Expenses Net(497)25  (150)68  
Earnings Before Interest And Taxes(21,104)(21,669)(22,729)(22,487)
Interest Expense -   -   -   -  
Income Before Tax(21,104)(21,669)(22,729)(22,487)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(21,104)(21,669)(22,729)(22,487)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (21,104) (21,669) (22,729) (22,487)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (21,104) (21,669) (22,729) (22,487)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.